ABSTRACT Absorption modeling has demonstrated its great value in modern drug product development due to its utility in understanding and predicting in vivo performance. In this case, we integrated physiologically based modeling in the development processes to effectively design extended-release (ER) clinical products for an ester prodrug LY545694. By simulating the trial results of immediate-release products, we delineated complex pharmacokinetics due to prodrug conversion and established an absorption model to describe the clinical observations. This model suggested the prodrug has optimal biopharmaceutical properties to warrant developing an ER product. Subsequently, we incorporated release profiles of prototype ER tablets into the absorption model to simulate the in vivo performance of these products observed in an exploratory trial. The models suggested that the absorption of these ER tablets was lower than the IR products because the extended release from the formulations prevented the drug from taking advantage of the optimal absorption window. Using these models, we formed a strategy to optimize the ER product to minimize the impact of the absorption window limitation. Accurate prediction of the performance of these optimized products by modeling was confirmed in a third clinical trial.
prodrug             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prodrug               

drug                          0.9804789690393595^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

pharmacokinetics              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pharmacokinetics      

absorption                    0.9999999999996589^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorption_(pharmacokinetics)

utility                       0.9999998464993614^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Utility               

ER                            0.8712234181954822^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Estrogen_receptor     

physiologically               0.9815878368693803^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Physiology            

absorption model              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Absorption_refrigerator

drug                          0.9804789690393595^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug                  

ER                            0.8712234181954822^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Estrogen_receptor     

absorption model              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Absorption_refrigerator

prodrug                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prodrug               

absorption                    0.9999999999996589^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorption_(pharmacokinetics)

absorption                    0.9999999999996589^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorption_(pharmacokinetics)

prodrug                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prodrug               

product development           0.6240713261479821^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/New_product_development

extended release              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Time_release_technology

ester                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ester                 

biopharmaceutical             0.6100817759228904^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_industry

IR                            0.9993106597651692^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Infrared              

ER                            0.8712234181954822^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Estrogen_receptor     

warrant                       0.5592203765848259^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Theory_of_justification

clinical trial                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Clinical_trial        

ER                            0.8712234181954822^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Estrogen_receptor     

ER                            0.8712234181954822^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Estrogen_receptor     

tablets                       0.9999995780666249^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Tablet_(pharmacy)     

prototype                     0.9975767648474927^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Prototype             

tablets                       0.9999995780666249^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Tablet_(pharmacy)     

